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Background
Every 40 seconds someone in the United States sustains a stroke, and
every four minutes an individual dies from this stroke (Rhew et al., 2017).
For each minute that a large-vessel occlusion, or ischemic stroke, goes
untreated 1.9 billion neurons and 13.8 billion synapses are lost which in
one hour is equivalent to the same loss that would occur in 3.6 years of
the natural aging process (Speirs & Mitchell, 2015).
The door-to-needle time (DNT) is the time that lapses between the time a
patient arrives in the emergency department (ED) and the time that
intravenous recombinant tissue plasminogen activator (tPA), otherwise
known as the pharmaceutical drug Alteplase is administered.

Hypothesis Statement
In patients with acute ischemic stroke symptoms arriving via personal
vehicle to the emergency department, does the use of an improved stroke
workflow and a standardized order set as opposed to the use of the
current stroke workflow and no order set decrease the average time from
door to Alteplase administration as measured in minutes?

Objectives
The overall aim of my capstone project is to decrease the time from door
to Alteplase (tPA) administration in applicable patients arriving to the
emergency department via personal vehicle in a community hospital.
 This overarching goal was to be met through the following objectives:
○Identify the areas of delay throughout the previous stroke process
○Find solutions to overcome these delays to insert logically into the
workflow
○Reorganize the workflow to prioritize obtaining the head CT before any
other menial tasks
○Improve interdisciplinary communication throughout the department
about stroke patient arrivals and treatment.
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Setting

Methods

The emergency department at this small Pennsylvania rural
hospital contains 18 beds and 4 triage suites contained in an
area known to staff as the pit.
The layout of the ED is thoughtfully done with the radiology
department directly outside the doors to the unit which allows
for easy access and transport of critical patients, namely those
suspected of having a stroke.

(Plan) The cycle begins with observing the current process and creating a new workflow
for approval by the stroke committee and emergency department management.
(Do) Once this is approved, education can be dispersed, and the implementation can be
brought about.
(Study) After a short period of implementation, the new workflow should be observed again
and feedback from staff as well as metrics should be collected and assessed.
(Act) Finally, utilizing this data and staff feedback, the workflow should be modified as
needed, if applicable, and new education provided throughout.
The projection as shown in the run chart is that the current door to Alteplase time frame,
while currently acceptable, continues to trend shorter to ensure the best possible patient
outcomes to a goal of 45 minutes or under by 2021

Literature Synthesis
Stroke is identified as the third leading cause of death by Rhew
et al. (2017), however Elder et al. (2015) and Speirs & Mitchell
(2015) identify stroke as the fourth leading cause of death in the
United States. The implication of this inconsistency is that
through the years, stroke prevalence has increased such that is
has moved up from the fourth leading cause in 2015 to the third
leading cause in 2017, meaning that there must be a focus today
on more education about stroke and prevention measures.
Recombinant tissue plasminogen activator (tPA), otherwise
known as the Food and Drug Administration (FDA) approved
pharmacological intervention, Alteplase, was unanimously stated
to be the primary standard treatment for acute ischemic stroke
(Emberson et al., 2014; Yang et al., 2014; Elder et al., 2015;
Speirs & Mitchell, 2015; Yoo et al., 2018; Zerna et al., 2018;
Campbell et al., 2019; Tennyson et al., 2019; Tran et al., 2019;
Jaffe et al., 2020; Kamal et al., 2020 Man et al., 2020).
Zerna et al. (2018) identified that approximately 25% of all
ischemic strokes are eligible for thrombolysis, however Rhew et
al. (2017) states that fewer than 5% of patients who are eligible
for acute treatment actually receive intravenous thrombolytic
drugs.
Zerna et al. (2018) states that they have found no average benefit
of Alteplase administration after 270 minutes, or 4.5 hours, from
stoke symptom onset and feel that to be the time as which the
medication approaches a neutral effect, as where Emberson et al.
(2014) estimated the time at which Alteplase has no effect to be
6.3 hours.
Risk versus benefit of Alteplase administration was not as heavily
discussed throughout the literature as one would assume given
that it carries severe and potentially life-threatening side effects
such as bleeding and subsequent intra-cranial hemorrhage
(Genentech USA, 2020). Campbell et al. revealed that “the
number of patients with symptomatic intracerebral hemorrhage
was significantly higher in the alteplase group than the placebo
group [...] however, no significant differences were identified in
mortality” (2019, p. 143)

Discussion
The implementation of this project was not abandoned - we developed
written and virtual education in the form of a pocket card for staff with
the streamlined new workflow and a more in-depth power-point
presentation explaining the reason for the change and the semantics of
the workflow.
This education and all steps from this point will be set aside and held
for future implementation after the Covid-19 pandemic subsides.

Significance
A single walk-through of the new workflow was completed by the
primary stroke coordinator with the unit educator on a single patient
and had successful outcomes.
As shown in the comparison chart below, the revised workflow
significantly reduced the times from door to intervention as compared
to the previous quarter’s average times.
This project has also empowered triage nurses to identify and call a
stroke alert independently without relying on a physician to confirm
their suspicions or write orders in the electronic medical record.

Results & Outcomes
The new workflow was developed, but in further discussion with the hospital stroke
committee it was suggested that we look into a nurse driven approach which would allow
the triage nurse to initiate the stroke alert process and take the patient to CT.
Identifying exact roles for each team member involved proved to be a setback as the
emergency department is an ever-changing environment in which staff availability and
patient acuity can fluctuate from hour to hour.
It was determined that flexibility will be paramount in this workflow; staff knowing the
steps of the new process in order will allow whichever staff is available to complete the
next chain in the process.
At this point in the implementation process the Covid-19 pandemic had begun to consume
the microsystem’s resources.
Over the following weeks as cases continued to rise, the ED management enacted a change
that all staff would be required to wear full personal protective equipment (PPE) garb to
enter the unit and such precious resources were understandably not to be utilized by
students.
Mental fatigue and staff burnout were also taken into consideration within this phase of the
PDSA cycle, and with Covid-related policy changes occurring sometimes daily we
ascertained that this was not the time to proceed with a major process change.
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